Hologicï¾’s COVID-19 tests detected Omicron variant
On Nov. 29, 2021, Hologic announced that its three SARS-CoV-2 tests all detected the recently emerged Omicron variant…
On Nov. 29, 2021, Hologic announced that its three SARS-CoV-2 tests all detected the recently emerged Omicron variant…
The COVID-19 Roller Coaster is a wild ride, strap yourself in and hold on… Cast of Characters: Senator…
On Nov. 26, 2021, Merck provided an update on the MOVe-OUT study of molnupiravir, an investigational oral antiviral…
On Nov. 26, 2021, the World Health Organization announced that the Technical Advisory Group on SARS-CoV-2 Virus Evolution…
On Nov. 25, 2021, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
On Nov. 24, 2021, Novavax announced its submission to the Singapore Health Sciences Authority for interim authorization of…
On Nov. 24, 2021, Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) had issued Emergency…
On Nov. 23, 2021, the World Health Organization’s COVID-19 Technology Access Pool and the Medicines Patent Pool finalized…
On Nov. 23, 2021, Oxitec announced the successful completion of the mosquito release phase of its landmark project…
On Nov. 22, 2021, Tonix Pharmaceuticals announced the publication of モSangivamycin is highly effective against SARS-CoV-2 in vitro…
On Nov. 22, 2021, Pfizer announced topline results from a longer-term analysis of the safety and efficacy of…
On Nov. 22, 2021, the U.S. Food and Drug Administration authorized another over-the-counter (OTC) COVID-19 antigen test. The…
On Nov. 21, 2021, Gavi, the Vaccine Alliance, announced that India has completed the national introduction of pneumococcal…
On Nov. 19, 2021, the U.S. Food and Drug Administration (FDA) announced that it had extended the emergency…
On Nov. 19, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had expanded…
On Nov. 18, 2021, Pfizer announced an agreement with the U.S. government to supply 10 million treatment courses…
On Nov. 18, 2021, CureVac announced the online publication of the extended preclinical study of the second-generation vaccine…
On Nov. 17, 2021, Novavax and and Serum Institute of India announced that the Philippine Food and Drug…
On Nov. 17, 2021, Novavax announced that the European Medicines Agency (EMA) had begun its evaluation of an…
On Nov. 17, 2021, Zosano Pharma announced that the Philippine Food and Drug Administration had granted emergency use…
On Nov. 17, 2021, Pacific Northwest National Laboratory (PNNL) announced researchers had compiled the most comprehensive road map…
On Nov. 17, 2021, GlaxoSmithKline and Vir Biotechnology announced U.S. government contracts totalling approximately $1 billion (USD) to…
On Nov. 17, 2021, scientists at the Centers for Disease Control and Prevention (CDC) announced they were collaborating…
On Nov. 16, 2021, Pfizer announced it had submitted an Emergency Use Authorization (EUA) of its investigational oral…
On Nov. 16, 2021, Pfizer and the Medicines Patent Pool (MPP), a United Nations-backed public health organization working…
On Nov. 16, 2021, an agreement was announced that enabled the European Union and European Economic Area countries…
On Nov. 16, 2021, Illumina and Genetic Alliance announced the creation of the iHopeï¾™ Genetic Health program aimed…
On Nov. 16, 2021, the University of Oxfordï¾’s and AstraZeneca announced that two billion doses of the ChAdOx1…
On Nov. 15, 2021, Novavax and SK bioscience announced submission of a Biologics License Application (BLA) for Novavax’…
On Nov. 15, 2021, Moderna confirmed that Health Canada had authorized the use of a booster dose of…